Shenshi Technology - About the company
Shenshi Technology is a series C company based in Beijing (China), founded in 2019. It operates as a Developer of AI-driven platform and tools for scientific research and development. Shenshi Technology has raised $255M in funding from investors like Qiming Venture Partners, Source Code Capital and Baidu Venture Capital. The company has 214 active competitors, including 71 funded and 13 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Valo Health.
Company Details
Developer of AI-driven platform and tools for scientific research and development. The platform offers resources for accessing academic literature, managing research projects, and running code. It provides a unified environment connecting software and hardware resources. The platform supports data management, environment replication, and team collaboration. It facilitates structured data analysis for scientific applications across various disciplines.
- Website
- www.dp.tech
- Email ID
- *****@dp.tech
- Phone Number
- +86 **********
Key Metrics
Founded Year
2019
Location
Beijing, China
Stage
Series C
Total Funding
$255M in 8 rounds
Latest Funding Round
Investors
Ranked
19th among 214 active competitors
Employee Count
105 as on Jun 30, 2026
Similar Companies
Sign up to download Shenshi Technology's company profile
Shenshi Technology's funding and investors
Shenshi Technology has raised a total funding of $255M over 8 rounds. Its first funding round was on Jul 2020. Its latest funding round was a Series C round on Dec 24, 2025 for $*****. 5 investors participated in its latest round. Shenshi Technology has 24 institutional investors.
Here is the list of recent funding rounds of Shenshi Technology:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 24, 2025 | 7223129 | Series C | 3943734 | 7032808 | 5977922 | 7915677 |
Oct 15, 2024 | 9277834 | Series B | 3739905 | 6369155 | 9458963 | 9128213 |
Aug 19, 2023 | 1571039 | Series B | 9969097 | 9992629 | 3923149 |
Access funding benchmarks and valuations. Sign up today!View details of Shenshi Technology's funding rounds and investors
Shenshi Technology's founders and board of directors
Founder? Claim ProfileShenshi Technology's employee count trend
Shenshi Technology has 105 employees as of Jun 26. Here is Shenshi Technology's employee count trend over the years:
Uncover Shenshi Technology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Shenshi Technology's Competitors and alternates
Top competitors of Shenshi Technology include Schrodinger, Recursion Pharmaceuticals and Valo Health. Here is the list of Top 10 competitors of Shenshi Technology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Schrodinger 1990, New York City (United States), Acquired | Provider of a web-based simulation and modelling tool | $162M | 74/100 | |
2nd | Recursion Pharmaceuticals 2013, New York (United States), Public | AI-enabled drug discovery and development platform for novel therapeutics | $452M | 72/100 | |
3rd |  Valo Health 2019, Boston (United States), Series B | AI-powered platform for drug discovery and development | $450M | 67/100 | |
4th |  XtalPi 2014, Cambridge (United States), Public | AI-based drug research and development company | $785M | 67/100 | |
5th |  Isomorphic Labs 2021, London (United Kingdom), Series B | Digital platform focused on revolutionizing drug discovery using AI | $2.7B | 64/100 | |
6th |  Xaira 2023, San Francisco (United States), Series D | AI-enabled platform for drug discovery and development | $1B | 63/100 | |
7th |  In Silico 2014, Cambridge (United States), Public | AI-enabled bioinformatics platform for drug discovery and biomarker development | $510M | 62/100 | |
8th |  Tandem AI 2021, New York (United States), Series A | AI-based drug discovery tool for researchers | $82M | 62/100 | |
9th | Causaly 2018, London (United Kingdom), Series B | Provider of an AI platform for life sciences and biomedical research | $93M | 62/100 | |
10th | Provider of an AI and quantum physics to discover therapeutic molecules | $101M | 62/100 | ||
19th |  Shenshi Technology 2019, Beijing (China), Series C | Developer of AI-driven platform and tools for scientific research and development | $255M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Shenshi Technology's competitors? Click here to see the top ones
Shenshi Technology's Investments and acquisitions
Shenshi Technology has made no investments or acquisitions yet.
Reports related to Shenshi Technology
Here is the latest report on Shenshi Technology's sector:
News related to Shenshi Technology
Media has covered Shenshi Technology for a total of 2 events in the last 1 year.
•
•
DP Technology Secures $109.6M+ Series C Funding for AI-Driven Scientific DiscoveryPandaily•Dec 25, 2025•Lenovo, Shenshi Technology, DT Capital, SCMP and 3 others
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Shenshi Technology
Explore our recently published companies
- Bomimo Nutrition - Unfunded company
- LC Elagage 74 - Chens-sur-leman based, 2004 founded, Unfunded company
- Smart Field Support - Netherlands based, 2019 founded, Unfunded company
- Seabury House - Unfunded company
- Summit Play - South Korea based, 2021 founded, Unfunded company
- High Honest - Unfunded company
